In vivo detection of vascular adhesion protein-1 in experimental inflammation

被引:95
作者
Jaakkola, K
Nikula, T
Holopainen, R
Vähäsilta, T
Matikainen, MT
Laukkanen, ML
Huupponen, R
Halkola, L
Nieminen, L
Hiltunen, J
Parviainen, S
Clark, MR
Knuuti, J
Savunen, T
Kääpä, P
Voipio-Pulkki, LM
Jalkanen, S
机构
[1] Univ Turku, Med City Res Lab, FIN-20520 Turku, Finland
[2] Univ Turku, Natl Publ Hlth Inst, FIN-20520 Turku, Finland
[3] Univ Turku, Dept Med, FIN-20520 Turku, Finland
[4] Univ Turku, Dept Nucl Med, FIN-20520 Turku, Finland
[5] Univ Turku, Dept Pharmacol & Clin Pharmacol, FIN-20520 Turku, Finland
[6] MAP Med Technol Inc, Tikkakoski, Finland
[7] Univ Turku, Turku, Finland
[8] Abo Acad Univ, Ctr Biotechnol, Turku, Finland
[9] Abo Acad Univ, Cardioresp Res Unit, Turku, Finland
[10] Abo Acad Univ, Dept Surg, Turku, Finland
[11] Univ Cambridge, Dept Pathol, Div Immunol, Cambridge CB2 1QP, England
[12] Orion Corp, Orion Pharma, Turku, Finland
[13] Turku Univ, Cent Hosp, Dept Nucl Med, Turku, Finland
基金
芬兰科学院;
关键词
D O I
10.1016/S0002-9440(10)64558-0
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Vascular adhesion protein-1 (VAP-1) is an inflammation-inducible endothelial glycoprotein which mediates leukocyte-endothelial cell interactions. To study the pathogenetic significance of VAP-1 in inflammatory disorders, an in vivo immunodetection method was used to detect the regulation of luminally expressed VAP-1 in experimental skin and joint inflammation in the pig and dog. Moreover, VAP-1 was studied as a potential target to localize inflammation by radioimmunoscintigraphy. Up-regulation of VAP-1 in experimental dermatitis and arthritis could be visualized by specifically targeted immunoscintigraphy. Moreover, the translocation of VAP-1 to the functional position on the endothelial surface was only seen in inflamed tissues. These results suggest that VAP-1 is both an optimal candidate for anti-adhesive therapy and a potential target molecule for imaging inflammation.
引用
收藏
页码:463 / 471
页数:9
相关论文
共 27 条
[1]  
ALMENARQUERALT A, 1995, AM J PATHOL, V147, P1278
[2]  
Armour KL, 1999, EUR J IMMUNOL, V29, P2613, DOI 10.1002/(SICI)1521-4141(199908)29:08<2613::AID-IMMU2613>3.0.CO
[3]  
2-J
[4]   Lymphocyte binding to vascular endothelium in inflamed skin revisited: A central role for vascular adhesion protein-1 (VAP-1) [J].
Arvilommi, AM ;
Salmi, M ;
Kalimo, K ;
Jalkanen, S .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (04) :825-833
[5]  
HEINZEL G, 1993, TOPFIT VERSION 2 0 P
[6]   LEUKOCYTE MIGRATION AND ADHESION [J].
IMHOF, BA ;
DUNON, D .
ADVANCES IN IMMUNOLOGY, VOL 58, 1995, 58 :345-416
[7]   Human vascular adhesion protein-1 in smooth muscle cells [J].
Jaakkola, K ;
Kaunismäki, K ;
Tohka, S ;
Yegutkin, G ;
Vänttinen, E ;
Havia, T ;
Pelliniemi, LJ ;
Virolainen, M ;
Jalkanen, S ;
Salmi, M .
AMERICAN JOURNAL OF PATHOLOGY, 1999, 155 (06) :1953-1965
[8]   Vascular adhesion protein-1, intercellular adhesion molecule-1 and P-selectin mediate leukocyte binding to ischemic heart in humans [J].
Jaakkola, K ;
Jalkanen, S ;
Kaunismäki, K ;
Vänttinen, E ;
Saukko, P ;
Alanen, K ;
Kallajoki, M ;
Voipio-Pulkki, LM ;
Salmi, M .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (01) :122-129
[9]  
KEELAN ETM, 1994, J NUCL MED, V35, P276
[10]   Analysis of Tie receptor tyrosine kinase in haemopoietic progenitor and leukaemia cells [J].
Kukk, E ;
Wartiovaara, U ;
Gunji, Y ;
Kaukonen, J ;
Buhring, HJ ;
Rappold, I ;
Matikainen, MT ;
Vihko, P ;
Partanen, J ;
Palotie, A ;
Alitalo, K ;
Alitalo, R .
BRITISH JOURNAL OF HAEMATOLOGY, 1997, 98 (01) :195-203